相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms
Ivan Borbath et al.
EUROPEAN JOURNAL OF CANCER (2022)
Long-term outcomes of resection versus transplantation for neuroendocrine liver metastases meeting the Milan criteria
Marianna Maspero et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2022)
Prior Resection of the Primary Tumor Prolongs Survival After Peptide Receptor Radionuclide Therapy of Advanced Neuroendocrine Neoplasms
Daniel Kaemmerer et al.
ANNALS OF SURGERY (2021)
Liver Embolisation for Patients with Neuroendocrine Neoplasms: Systematic Review
Rahul Kanabar et al.
NEUROENDOCRINOLOGY (2021)
The effect of primary site, functional status and treatment modality on survival in gastroenteropancreatic neuroendocrine neoplasms with synchronous liver metastasis: a US population-based study
Ning Pu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Postrecurrence Survival After Liver Transplantation for Liver Metastases From Neuroendocrine Tumors
Carlo Sposito et al.
TRANSPLANTATION (2021)
Efficacy of 177Lu-Dotatate Induction and Maintenance Therapy of Various Types of Neuroendocrine Tumors: A Phase II Registry Study
Golmehr Sistani et al.
CURRENT ONCOLOGY (2021)
Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis
Michael E. Egger et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2020)
Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors
Ashley L. Titan et al.
JAMA NETWORK OPEN (2020)
Peptide Receptor Radionuclide Therapy as First-Line Systemic Treatment in Advanced Inoperable/Metastatic Neuroendocrine Tumors
Swayamjeet Satapathy et al.
CLINICAL NUCLEAR MEDICINE (2020)
Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver Transplantation
Andrea Ruzzenente et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2019)
Surgery for Pancreatic Neuroendocrine Tumor G3 and Carcinoma G3 Should be Considered Separately
Tsukasa Yoshida et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study
Esben Andreas Carlsen et al.
ENDOCRINE-RELATED CANCER (2019)
Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma
Tingting Feng et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)
Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors
John F. Tierney et al.
SURGERY (2019)
Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs)
Aaron T. Scott et al.
SURGERY (2019)
Long-Term Toxicity after Transarterial Radioembolization with Yttrium-90 Using Resin Microspheres for Neuroendocrine Tumor Liver Metastases
Yuki Tomozawa et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms
Stefano Partelli et al.
SURGERY (2018)
Expanded criteria for debulking of liver metastasis also apply to pancreatic neuroendocrine tumors
Rosemary E. Morgan et al.
SURGERY (2018)
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver (RETNET): study protocol for a randomized controlled trial
James X. Chen et al.
TRIALS (2018)
A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
Guido Rindi et al.
MODERN PATHOLOGY (2018)
Initial Treatment of Unresectable Neuroendocrine Tumor Liver Metastases with Transarterial Chemoembolization using Streptozotocin: A 20-Year Experience
Mashaal Dhir et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival
James X. Chen et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2017)
Intra-arterial therapy of neuroendocrine tumour liver metastases: comparing conventional TACE, drug-eluting beads TACE and yttrium-90 radioembolisation as treatment options using a propensity score analysis model
Duc Do Minh et al.
EUROPEAN RADIOLOGY (2017)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas
R. B. Galleberg et al.
EJSO (2017)
Recent updates on grading and classification of neuroendocrine tumors
Joo Young Kim et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2017)
Surgery for Cancer: A Trigger for Metastases
Samer Tohme et al.
CANCER RESEARCH (2017)
The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors
V. Mazzaferro et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases
Emilio Bertani et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy?
Jessica E. Maxwell et al.
SURGERY (2016)
Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters
Stefano Crippa et al.
SURGERY (2016)
Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors
Xavier M. Keutgen et al.
SURGERY (2016)
Long-Term Outcomes of Surgical Management of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases
Stefano Partelli et al.
NEUROENDOCRINOLOGY (2015)
Surgical Management of Advanced Pancreatic Neuroendocrine Tumors: Short-Term and Long-Term Results from an International Multi-institutional Study
David Jeremie Birnbaum et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Expanded criteria for carcinoid liver debulking: Maintaining survival and increasing the number of eligible patients
Amanda N. Graff-Baker et al.
SURGERY (2014)
Long Term Survival Analysis of Hepatectomy for Neuroendocrine Tumour Liver Metastases
Tan To Cheung et al.
SCIENTIFIC WORLD JOURNAL (2014)
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors
Francesco Fiore et al.
ENDOCRINE (2014)
Liver Transplantation for Neuroendocrine Tumors in Europe-Results and Trends in Patient Selection A 213-Case European Liver Transplant Registry Study
Yves Patrice Le Treut et al.
ANNALS OF SURGERY (2013)
Phase II Study of Chemoembolization With Drug-Eluting Beads in Patients With Hepatic Neuroendocrine Metastases: High Incidence of Biliary Injury
Nikhil Bhagat et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Metastatic neuroendocrine tumors to the liver: treatment with bland embolization versus radioembolization
T.A. Gebhard et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Radioembolization of Symptomatic, Unresectable Neuroendocrine Hepatic Metastases Using Yttrium-90 Microspheres
Philipp M. Paprottka et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2012)
Radioembolization for Neuroendocrine Liver Metastases: Safety, Imaging, and Long-Term Outcomes
Khairuddin Memon et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Hepatic Arterial Embolization versus Chemoembolization in the Treatment of Liver Metastases from Well-Differentiated Midgut Endocrine Tumors: A Prospective Randomized Study
Frederique Maire et al.
NEUROENDOCRINOLOGY (2012)
Surgery Versus Intra-arterial Therapy for Neuroendocrine Liver Metastasis: A Multicenter International Analysis
Skye C. Mayo et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Liver Transplantation for the Treatment of Liver Metastases From Neuroendocrine Tumors An Analysis of the UNOS Database
Roberto Gedaly et al.
ARCHIVES OF SURGERY (2011)
Impact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapy
Samer Ezziddin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study
Lisa Bodei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated With Disease Progression
Francesco Panzuto et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Response and Long-Term Control of Bone Metastases After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
Samer Ezziddin et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Hepatic artery chemoembolization for the treatment of liver metastases from neuroendocrine tumors: a long-term follow-up in 123 patients
Xiang Da Dong et al.
MEDICAL ONCOLOGY (2011)
Neuroendocrine Liver Metastases and Orthotopic Liver Transplantation: The US Experience
N. Thao T. Nguyen et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2011)
Surgical Management of Hepatic Neuroendocrine Tumor Metastasis: Results from an International Multi-Institutional Analysis
Skye C. Mayo et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases
C. Q. Cao et al.
BRITISH JOURNAL OF SURGERY (2010)
Long-term survival after surgical management of neuroendocrine hepatic metastases
Evan S. Glazer et al.
HPB (2010)
Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumor
Daniel Kaemmerer et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres:: Early results in 148 patients
Andrew S. Kennedy et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
T. R. Halfdanarson et al.
ANNALS OF ONCOLOGY (2008)
90Y radioembolization for metastatic neuroendocrine liver tumors -: Preliminary results from a multi-institutional experience
Thomas K. Rhee et al.
ANNALS OF SURGERY (2008)
Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours
Ulrich-Frank Pape et al.
ENDOCRINE-RELATED CANCER (2008)
Treatment with the radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3] octreotate:: Toxicity, efficacy, and survival
Dik J. Kwekkeboom et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Hepatic Neuroendocrine Metastases: Chemo- or Bland Embolization?
Susan C. Pitt et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors
Anthony J. Chambers et al.
SURGERY (2008)
Surgery in malignant pancreatic neuroendocrine tumors
Scott Q. Nguyen et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver
Alexander T. Ruutiainen et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2007)
Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors
Alexander S. Ho et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2007)
Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: Lessons learned
Mark Bloomston et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2007)
Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors - An institutional experience
Paulus G. Schurr et al.
ANNALS OF SURGERY (2007)
Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival
Babak Givi et al.
SURGERY (2006)
Resection of pancreatic neuroendocrine tumors - Results of 70 cases
Kevork K. Kazanjian et al.
ARCHIVES OF SURGERY (2006)
Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced
R Valkema et al.
SEMINARS IN NUCLEAR MEDICINE (2006)
Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors
DA Osborne et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors - Variables affecting response rates and survival
S Gupta et al.
CANCER (2005)
Endocrine tumours of the pancreas
K Öberg et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2005)
Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease
EA Danna et al.
CANCER RESEARCH (2004)
Surgical treatment of neuroendocrine metastases to the liver: A plea for resection to increase survival
JM Sarmiento et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2003)
Aggressive surgery for metastatic liver neuroendocrine tumors
JA Norton et al.
SURGERY (2003)
Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors - A retrospective single-center analysis
O Kress et al.
DIGESTION (2003)
Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide:: The Rotterdam experience
R Valkema et al.
SEMINARS IN NUCLEAR MEDICINE (2002)
分享论文
